PROFECTUS BIOSCIENCES, INC.

Address

6411 Beckley St
BALTIMORE, MD, 21224-6538

Information

DUNS: 185576639
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Therapeutic Vaccine for Walnut and Pecan Allergies

    Amount: $241,464.00

    Abstract IgE mediated food allergies have become a major public health concern now estimated to affect of children under years old and of adults in the US Approximately emergency h ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. DNA Prime / Subunit Boost Multi-Antigen Universal Influenza Vaccine

    Amount: $299,921.00

    ABSTRACT A universal influenza vaccine is believed to be possible if conserved regions of influenza are effectively targeted and appropriate immune responses are generated against those targets The e ...

    SBIRPhase I2016Department of Health and Human Services
  3. Novel Mucosal Adjuvant for an HIV DNA Vaccine

    Amount: $1,467,264.00

    DESCRIPTION provided by applicant Our primary approach to develop an effective prophylactic vaccine against HIV utilizes a novel immunogen called the Full Length Single Chain FLSC that consists o ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  4. Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine

    Amount: $1,967,443.00

    DESCRIPTION The HIV pandemic is one of the greatest public health challenges in history It is estimated that million people are living with HIV and million of those are newly infected In a nu ...

    SBIRPhase II2015Department of Health and Human Services
  5. Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine

    Amount: $238,756.00

    DESCRIPTION: There is a growing consensus that protection against HIV infection will require BOTH antiviral antibody responses as well as polyfunctional CD4+ and CD8+ T cells with potent lytic activit ...

    SBIRPhase I2014Department of Health and Human Services
  6. Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine

    Amount: $3,299,996.00

    DESCRIPTION: The HIV pandemic is one of the greatest public health challenges in history. It is estimated that 33 million people are living with HIV and 2.7 million of those are newly infected In a nu ...

    SBIRPhase I2014Department of Health and Human Services
  7. An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC

    Amount: $2,300,000.00

    DESCRIPTION Based on the prevailing evidence we believe that a highly effective vaccine for HIV prophylaxis must induce long lasting broadly cross reactive antibody responses to envelope that exhib ...

    SBIRPhase I2014Department of Health and Human Services
  8. Optimization of a DNA Subunit Regimen for an HIV Vaccine

    Amount: $2,700,194.00

    DESCRIPTION provided by applicant Our primary approach to develop an effective prophylactic vaccine against HIV utilizes a novel immunogen called the Full Length Single Chain FLSC that consists of gp ...

    SBIRPhase II2013Department of Health and Human Services
  9. Prime/Boost Vaccine to Prevent Hepatocellular Carcinoma

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): This SBIR application proposes to pre-clinically evaluate a pDNA prime - rVSV boost HCV vaccine intended to improve the sustained virologic response (SVR) rate in ...

    SBIRPhase I2012Department of Health and Human Services
  10. Optimization of a DNA Subunit Regimen for an HIV Vaccine

    Amount: $224,027.00

    DESCRIPTION (provided by applicant): Our primary approach to develop an effective prophylactic vaccine against HIV utilizes a novel immunogen called the Full Length Single Chain (FLSC) that consists o ...

    SBIRPhase I2012Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government